Ginkgo Bioworks Holdings, Inc.

Historical 13F Holders

Symbol
DNA
CUSIP
37611X100
All holders as of
Q2 2026
Type
Equity
Class
CL A SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 37611X100 since 12/18/2024, largest first.

Filer % of Class Filed
Baillie Gifford & Co 13G/A 6.5% 2/12/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 1 4.00 $29.00
2025 Q1 1 607 k $203 k
2024 Q3 9 21.9 k $150 k
2024 Q2 328 940 M $314 M
2024 Q1 356 1.39 B $1.62 B
2023 Q4 362 1.32 B $2.22 B
2023 Q3 365 1.24 B $2.25 B
2023 Q2 332 1.21 B $2.25 B
2023 Q1 329 1.14 B $1.51 B
2022 Q4 353 1.01 B $1.70 B
2022 Q3 308 879 M $2.75 B
2022 Q2 285 788 M $1.93 B
2022 Q1 218 667 M $2.68 B
2021 Q4 192 897 M $7.40 B
2021 Q3 147 792 M $9.18 B
2020 Q2 1 15.0 k $36.0 k